Home / Japan / Oncolys BioPharma Inc.
Oncolys BioPharma Inc.
Short position disclosed on September 16, 2026.
1.76% of the capital sold short
2 disclosing funds
95 disclosures on record
Evolution of the disclosed total
0%5%10%15%
Aug 13Aug 22Aug 31Sep 9Sep 18
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Jane Street Asia Trading Limited | 1.27% | new | September 16, 2026 | |
| Goldman Sachs International | 0.49% | new | September 16, 2026 |
Get the moves on Oncolys BioPharma Inc. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 95 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 12.36% of the capital sold short
- Towa Corporation 10.49% of the capital sold short
- TESS Holdings Co.,Ltd. 6.97% of the capital sold short
- Unitika LTD. 6.96% of the capital sold short
- Jibannet Holdings Co.,Ltd. 6.90% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.52% of the capital sold short
- Toyo Engineering Corporation 6.29% of the capital sold short
- JSH Co.,Ltd. 5.97% of the capital sold short
- Datasection Inc. 5.83% of the capital sold short
- Def consulting,inc. 5.76% of the capital sold short
- Tri Chemical Laboratories Inc. 5.71% of the capital sold short
- Toho Zinc Co.,Ltd. 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Oncolys BioPharma Inc., source JPX, data as at September 16, 2026, https://www.quivad.com/action/oncolys-biopharma-inc?page=2